{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:17:06Z","timestamp":1793456226212,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Hereditary \u03b1-tryptasemia (H\u03b1T), defined by increased\n                      <jats:italic>TPSAB1<\/jats:italic>\n                      copy number and elevated basal serum tryptase, is associated with mast cell (MC)\u2013mediated symptoms. However, its role in gastrointestinal disease remains unclear. Because intestinal MCs express the non\u2013IgE-dependent activation receptor MRGPRX2, we investigated whether MRGPRX2 expression and MC phenotypes are altered in individuals with H\u03b1T in the context of inflammatory bowel disease (IBD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We genotyped 854 biobanked IBD samples to identify individuals with H\u03b1T. Spatial transcriptomic analysis was performed on descending colon tissue from individuals with H\u03b1T (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094) as well as tissue and severity matched non-H\u03b1T controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094). Small intestinal biopsies were additionally analyzed using mass cytometry (CyTOF) from H\u03b1T individuals (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095) and non-H\u03b1T controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099). Droplet digital PCR (ddPCR) was used to establish TPSAB1 copy number variant for H\u03b1T detection. Comparisons across groups were performed using Welch's\n                      <jats:italic>t<\/jats:italic>\n                      -test with effect sizes and 95% CI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Across complementary platforms, H\u03b1T was associated with increased gastrointestinal mast cell abundance and elevated expression of mast cell activation markers, including CD203c, LAMP-1, and SIGLEC8. Both spatial transcriptomics and ddPCR demonstrated significantly increased\n                      <jats:italic>MRGPRX2<\/jats:italic>\n                      and\n                      <jats:italic>SIGLEC8<\/jats:italic>\n                      transcript levels in IBD samples from individuals with H\u03b1T compared with matched non-H\u03b1T IBD controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that enhanced MRGPRX2 expression and mast cell activation may contribute to gastrointestinal symptoms in individuals with H\u03b1T, particularly in the setting of IBD. As interest in precision immunogenetics grows, defining mast cell phenotypes linked to \u03b1-tryptase copy number may help refine diagnostic evaluation and identify patients who could benefit from emerging mast cell\u2013targeted therapeutic strategies in the context of IBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/falgy.2025.1726096","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:44:21Z","timestamp":1768977861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary \u03b1-tryptasemia"],"prefix":"10.3389","volume":"6","author":[{"given":"Michelle","family":"Galeas-Pena","sequence":"first","affiliation":[{"name":"Section of Gastroenterology, Department of Medicine, Tulane University School of Medicine","place":["New Orleans, LA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Lyons","sequence":"additional","affiliation":[{"name":"Division of Allergy & Immunology, Department of Medicine, University of California San Diego","place":["La Jolla, CA, United States"]},{"name":"Veterans Affairs San Diego Healthcare System","place":["La Jolla, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhana","family":"Llivichuzhca-Loja","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine","place":["New Haven, CT, United States"]},{"name":"Department of Immunobiology, Yale University School of Medicine","place":["New Haven, CT, United States"]},{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Everman","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center","place":["Jackson, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghina","family":"Yaghi","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Department of Medicine, Tulane University School of Medicine","place":["New Orleans, LA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"White","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Department of Medicine, Tulane University School of Medicine","place":["New Orleans, LA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita","family":"Sutradhar","sequence":"additional","affiliation":[{"name":"Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya O.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center","place":["Jackson, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.","family":"Owings","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center","place":["Jackson, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha S.","family":"Dhaliwal","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center","place":["Jackson, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Carlye","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center","place":["Jackson, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Konnikova","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine","place":["New Haven, CT, United States"]},{"name":"Department of Immunobiology, Yale University School of Medicine","place":["New Haven, CT, United States"]},{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hydar","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Glover","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Department of Medicine, Tulane University School of Medicine","place":["New Orleans, LA, United States"]},{"name":"Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center","place":["Jackson, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","article-title":"Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms","volume":"7","author":"Chovanec","year":"2023","journal-title":"Blood Adv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human \u03b1\/\u03b2-tryptase heterotetramers in the pathogenesis of hereditary \u03b1-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11882-024-01136-y","article-title":"Alpha-tryptase as a risk-modifying factor for mast cell-mediated reactions","volume":"24","author":"Shin","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e76116","DOI":"10.1371\/journal.pone.0076116","article-title":"Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome","volume":"8","author":"Matito","year":"2013","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11882-019-0887-x","article-title":"Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations","volume":"19","author":"Khoury","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jaci.2021.04.004","article-title":"Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia","volume":"148","author":"Konnikova","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.anai.2021.08.009","article-title":"Clinical relevance of inherited genetic differences in human tryptases: hereditary alpha-tryptasemia and beyond","volume":"127","author":"Glover","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"B11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","article-title":"Mast cell tryptases in allergic inflammation and immediate hypersensitivity","volume":"72","author":"Lyons","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.anai.2021.06.019","article-title":"Inherited and acquired determinants of serum tryptase levels in humans","volume":"127","author":"Lyons","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic regulation of tryptase production and clinical impact: hereditary alpha tryptasemia, mastocytosis and beyond","volume":"22","author":"Sprinzl","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/medicina57020124","article-title":"Mast cell activation disorders","volume":"57","author":"Giannetti","year":"2021","journal-title":"Medicina"},{"key":"B15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41575-020-0309-5","article-title":"IgE producers in the gut expand the gut\u2019s role in food allergy","volume":"17","author":"Iweala","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2021.04.004","article-title":"Understanding mast cell heterogeneity at single cell resolution","volume":"42","author":"Cildir","year":"2021","journal-title":"Trends Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e20230570","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1151754","DOI":"10.3389\/fimmu.2023.1151754","article-title":"Analysis of human lung mast cells by single cell RNA sequencing","volume":"14","author":"R\u00f6nnberg","year":"2023","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/jpet.103.061291","article-title":"Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release","volume":"309","author":"He","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: new insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1053\/j.gastro.2020.12.076","article-title":"Inflamed ulcerative colitis regions associated with MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/0022034520919107","article-title":"Roles of a mast cell-specific receptor MRGPRX2 in host defense and inflammation","volume":"99","author":"Chompunud Na Ayudhya","year":"2020","journal-title":"J Dent Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coi.2021.03.011","article-title":"Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs","volume":"72","author":"Ali","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2024.07.002","article-title":"Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists","volume":"154","author":"Wollam","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/cea.14264","article-title":"Clonal mast cell disorders and hereditary \u03b1-tryptasemia as risk factors for anaphylaxis","volume":"53","author":"Ka\u010dar","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","article-title":"Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome","volume":"150","author":"Wouters","year":"2016","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/gutjnl-2024-334037","article-title":"Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome","volume":"74","author":"Decraecker","year":"2025","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003537","article-title":"Hereditary alpha-tryptasemia is associated with ongoing symptoms in individuals with celiac disease despite following a gluten-free diet","author":"Therrien","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41385-018-0047-y","article-title":"High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue","volume":"11","author":"Konnikova","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cell.2020.12.016","article-title":"Spatiotemporal analysis of human intestinal development at single-cell resolution","volume":"184","author":"Fawkner-Corbett","year":"2021","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/MIB.0000000000000142","article-title":"The multifaceted mast cell in inflammatory bowel disease","volume":"20","author":"Hamilton","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1073\/pnas.1005758108","article-title":"Essential role for mast cell tryptase in acute experimental colitis","volume":"108","author":"Hamilton","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.2834","article-title":"The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells","volume":"15","author":"Kurachi","year":"2014","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"29406","DOI":"10.1074\/jbc.M112.348946","article-title":"The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis","volume":"287","author":"Chan","year":"2012","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/3877","article-title":"Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency","volume":"20","author":"Puel","year":"1998","journal-title":"Nat Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/all.16146","article-title":"The effects of inhaled corticosteroids on healthy airways","volume":"79","author":"Marchi","year":"2024","journal-title":"Allergy"},{"key":"B43","doi-asserted-by":"publisher","first-page":"833728","DOI":"10.3389\/fimmu.2022.833728","article-title":"The inhibitory receptor siglec-8 interacts with Fc\u03b5RI and globally inhibits intracellular signaling in primary mast cells upon activation","volume":"13","author":"Korver","year":"2022","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ejhg.2009.239","article-title":"Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma","volume":"18","author":"Gao","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/cei\/uxad095","article-title":"Compartment-driven imprinting of intestinal CD4T cells in inflammatory bowel disease and homeostasis","volume":"214","author":"Lutter","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/j.1365-2222.2009.03374.x","article-title":"Histamine, histamine receptors and their role in immune pathology","volume":"39","author":"Jutel","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41385-020-00336-9","article-title":"A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation","volume":"14","author":"Schanin","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2023-181476","article-title":"Optimizing Siglec-8-directed immunotherapy for eosinophilic and mast cell disorders","volume":"142","author":"Huo","year":"2023","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2500\/aap.2025.46.240088","article-title":"Appraisal of the evidence linking hereditary \u03b1-tryptasemia with mast cell disorders, hypermobility and dysautonomia","volume":"46","author":"Lyons","year":"2025","journal-title":"Allergy Asthma Proc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jaip.2022.11.042","article-title":"Mast cell activation syndromes: comparison between two scoring models to predict for mast cell clonality","volume":"11","author":"Rama","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/all.15911","article-title":"Clinical impact of the TPSAB1 genotype in mast cell diseases: a REMA study in a cohort of 959 individuals","volume":"79","author":"Gonz\u00e1lez-de-Olano","year":"2024","journal-title":"Allergy"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1726096\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:40:44Z","timestamp":1771918844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1726096\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":54,"alternative-id":["10.3389\/falgy.2025.1726096"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1726096","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1726096"}}